查詢結果分析
相關文獻
- 以牛樟芝餵食小鼠28天亞急性毒性試驗之組織病理與生化分析
- 基因毒性試驗--體外鼷鼠淋巴瘤 tk 分析法
- 染色體異常分析於基因毒性試驗之應用
- 加拿大國民最關心的食品安全--健康食品
- 微生物類健康食品與相關法規
- 藥材菇牛樟芝產品作為膳食補充劑及新膳食成分的美國法規系統
- Establishment of a Standardized Animal Model of Chronic Hepatotoxicity Using Acetaminophen-Induced Hepatotoxicity in the Evaluation of Hepatoprotective Effects of Health Food
- 食品科技與現代文明的反思
- 牛樟椴木栽培之牛樟芝子實體的大鼠90天重複劑量亞慢性毒性評估
- 我國健康食品製造良好作業規範與歐美管理制度之探討
頁籤選單縮合
| 題 名 | 以牛樟芝餵食小鼠28天亞急性毒性試驗之組織病理與生化分析=Histopathology and Biochemistry Analysis in a 28-day Subacute Toxicological Assessment of Antrodia cinnamomea in BALB/c Mice |
|---|---|
| 作 者 | 吳銘芳; 李美慧; 黃韶顏; 劉嘉又; 鍾明燈; 常傳訓; 敖曼冠; 廖年捷; 薛樹清; 呂旭峰; | 書刊名 | Journal of Biomedical & Laboratory Sciences |
| 卷 期 | 24:1 2012.03[民101.03] |
| 頁 次 | 頁5-11 |
| 分類號 | 415.198 |
| 關鍵詞 | 牛樟芝; 毒性試驗; 小鼠; 健康食品; 食品安全; |
| 語 文 | 中文(Chinese) |
| DOI | 10.30046/JBLS.201103.0007 |
| 中文摘要 | 在台灣,非處方之中草藥常被用來治療腹痛、高血壓與肝腫瘤,並逐漸被全世界所採用。在東方世界,這些中草藥之中又以牛樟芝為最有名的調理聖品,因此提供毒理檢查已確定食品安全性有其必要。本研究建立小鼠(BALB/c mice)28天口服亞急性毒性分析模式,在每組十隻老鼠且雌雄分別下,以16.7、833.3與1666.7毫克/公斤/天三種劑量連續28天口服餵食,觀察其亞急性毒性反應。各組老鼠在實驗最後仍皆存活,且實驗組老鼠之血液與生化檢驗結果皆與對照組無統計學差異,進ㄧ部的肝臟、腎臟及脾臟的組織切片分析顯示各組皆未有明顯的病理與毒理變化。因此,從此實驗結果可瞭解到未觀察到毒性的劑量至少為1666.7 mg/kg/天。 |
| 英文摘要 | Objective: Non-prescriptional use of medicinal herbs is highly prevalent to treat abdominal pain, hypertension and hepatocellular carcinoma in Taiwan and increasing worldwide. Among them, Antrodia cinnamomea was the most famous modalities being consumed especially among Oriental. Since the use of Antrodia cinnamomea in herbal medicines is increased, toxicity studies are warranted to confirm the safe use of Antrodia cinnamomea. Based on the 28-day subacute oral toxicity studies of Antrodia cinnamomea extract in male and female BALB/c mice, the extract at doses of 16.7, 833.3, and 1666.7mg/kg/day were administered by oral gavage to groups of mice (10 mice/dose) for 28 consecutive days and sterile water was used as control. All animals survived to the end of the study. No significant differences were found in hematology and serum biochemistry parameters among the control and treatment groups. Further histological examination in liver, kidney and spleen showed no pathological changes among all groups. These results suggest that the no-observed-adverse-effect level (NOAEL) of the extract for male and female mice is considered to be 1666.7 mg/kg/day. |
本系統中英文摘要資訊取自各篇刊載內容。